Integra LifeSciences saw the highest growth of 0.99% in patent filings and 2.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.7% and grants by 1.09%. GlobalData’s DataBook provides a comprehensive analysis of Integra LifeSciences’s patent filings and grants. Buy the databook here.
Integra LifeSciences has been focused on protecting inventions in United States(US) with 19 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 55% filings and 41% grants. The United States(US), European Patent Office(EPO), China(CN), and Australia(AU) patent Office are among the top ten patent offices where Integra LifeSciences is filings its patents. Among the top granted patent authorities, Integra LifeSciences has 41% of its grants in United States(US), 22% in Israel(IL) and 12% in European Patent Office(EPO).
Olympus and Johnson & Johnson could be the strongest competitors for Integra LifeSciences
Patents related to healthtech and climate change lead Integra LifeSciences's portfolio
Integra LifeSciences has the highest number of patents in healthtech followed by, climate change and health and safety. For healthtech, nearly 100% of patents were filed and 53% of patents were granted in Q2 2024.
General surgery devices related patents lead Integra LifeSciences portfolio followed by diagnostic imaging, and neurology devices
Integra LifeSciences has highest number of patents in general surgery devices followed by diagnostic imaging, neurology devices, ent devices, and image guided surgery. For general surgery devices, nearly 64% of patents were filed and 45% of patents were granted in Q2 2024.
For comprehensive analysis of Integra LifeSciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.